The prophylactic efficacy of Anatolian propolis in individuals at high risk of COVID-19
Künye
Guler, E., Bilir, O., Osman Kocak, A., Atas, I., & Tanugur Samanci, A. E. (2022). The prophylactic efficacy of Anatolian propolis in individuals at high risk of COVID-19. European review for medical and pharmacological sciences, 26(2 Suppl), 53–60. https://doi.org/10.26355/eurrev_202212_30483Özet
OBJECTIVE: No prophylactic
treatment is available for individuals at high risk of
developing COVID-19. This study, which was conducted between December 25, 2020, and January
25, 2021, is one of the first clinical studies to evaluate the efficacy of Anatolian propolis supplement
against COVID-19. The aim was to obtain evidence
on the prophylactic use of Anatolian propolis in individuals at high risk of developing COVID-19.
SUBJECTS AND METHODS: This volunteer-based study was conducted in two centers.
The study involved 209 healthcare professionals (physicians, nurses, medical secretaries) from
Emergency Medicine Department of Medical Faculty of Ataturk University and Emergency Medicine Department of Rize Recep Tayyip Erdogan
University. 204 participants meeting the study criteria were divided into two groups as experimental
group and control group. The experimental group
received 20 drops of BEE’O UP (BEE&YOU) 30%
Propolis drops twice a day during a follow-up period of 1 month. The control group received no
supplement but was followed up. The participants
showing symptoms during the study and all the
participants at the end the study were subjected to
PCR testing.
RESULTS: The evaluation of the results of PCR
testing at the end of the study has shown that 14
participants from the control group and only 2
participants from the experimental group, who received Anatolian propolis supplement, were reported as positive cases.
CONCLUSIONS: It has been found that a
statistically significant protection was induced
against COVID-19 infection in 98% of the experimental group, who received Anatolian propolis,
compared to the control group.